✦ LIBER ✦

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Scribed by Takayuki Fukui; Tetsuya Mitsudomi

Publisher: Springer Japan
Year: 2008
Tongue: Japanese
Weight: 265 KB
Volume: 56
Category: Article
ISSN: 1863-6705
DOI: 10.1007/s11748-007-0193-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Impact of epidermal growth factor recept

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

✍ Jeeyun Lee; Kee-Taek Jang; Chang-Seok Ki; Taekyu Lim; Young Suk Park; Ho Yeong L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

## Abstract ## BACKGROUND. Erlotinib, in combination with gemcitabine, has shown clinical benefits in pancreatic adenocarcinoma patients. The presence of __EGFR__ mutations and increased __EGFR__ copy numbers in pancreatic adenocarcinoma was explored. ## METHODS. Sixty‐six pancreatic cancer pati

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Somatic mutations of epidermal growth fa

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

✍ Hisayuki Shigematsu; Adi F. Gazdar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 540 KB

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers have generated enormous interest, because they predict for sensitivity to TK inhibitors (TKIs). While mutational status is of great importance in determining response to TKIs, it

Salicylanilides as Inhibitors of the Pro

Salicylanilides as Inhibitors of the Protein Tyrosine Kinase Epidermal Growth Factor Receptor.

✍ Christoph Liechti; Urs Sequin; Guido Bold; Pascal Furet; Thomas Meyer; Peter Tra 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 100 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer : Impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors

✍ Victor Cohen; Jason S. Agulnik; Celina Ang; Goulnar Kasymjanova; Gerald Batist; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) kinase domain are associated with sensitivity to EGFR‐tyrosine kinase inhibitors (EGFR‐TKI) in patients with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors tested the possibility that nucleoti